NCT01234649 Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) Status COMPLETED Phase PHASE3
NCT01234545 Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors Status COMPLETED Phase N/A
NCT01232491 Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01230021 Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency Status COMPLETED Phase PHASE3
NCT01228669 Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B Status COMPLETED Phase PHASE1
NCT01226966 Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase N/A
NCT01223911 A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01220141 Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B Status COMPLETED Phase N/A
NCT01215435 Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone Status COMPLETED Phase PHASE4
NCT01212133 A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India Status COMPLETED Phase N/A
NCT01208506 First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01208012 Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01206101 Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation Status TERMINATED Phase PHASE2
NCT01205724 Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A Status COMPLETED Phase PHASE1
NCT01193387 Comparison of Two Identical NN1250 Formulations in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01186003 Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy Status COMPLETED Phase NA
NCT01180530 Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes Status COMPLETED Phase N/A